Week 58 Review

An action packed week with some strategic sales of some long standing shares, and some amazing weekly performances.

On paper, the worst performing share was my ISA holding of KIBO:Kibo Mining, which dropped 52%. However, this was just a trick as my £600 original purchase for 3.725p was blatted by £2,000 worth purchased this week at 8.825p, so although the share price soared, the percentage increase got a hammering.

The only real double digit loser this week was IOG:Independent Oil & Gas, which dropped 26% and may drop further before the next news, which is likely to be either the results of the test drill analysis or on the Vulcan field.

Lots of big risers this week, starting with CRL:Creightons, which after a long static period climbed by 18% this week. This is another share I wish I'd got more of, and may top up on, but it has a huge spread so it's taken a year to get into profit. The £151 potential profit is very welcome though.

The standard share account version of KIBO:Kibo Mining told a more realistic story than the ISA, climbing 34% and taking the potential profit to £1,364 between the two accounts. This has moved it past CWR:Ceres Power and into the Star Share position.

TLOU:Tlou Energy climbed an amazing 42% this week, following results on Monday. This has a long way to go, but could prove an excellent earner if the project succeeds.

You'd think that would be enough for Share of the Week, but it's not. That title goes to RED:RedT Energy which also climbed 42%, but as I bought some more of these just before they stepped up, I've decided to award the prize to them

Here's the effect on the main share and ISA portfolios

			Weekly Change
Portfolio cost	£41,206.60		+£1,417.17
Portfolio sell value (bid price - commission)	£39,610.71	(-3.9%)	+£568.93
Potential profits	£3,773.78		+£679.54
Yr 2 Dividends	£105.48		+£0
Yr 2 Profit from sales	£2,303.91		-£59.46
Yr 2 Average monthly cash profit	£1,737.41		-£399.01
Yr 2 Avg annual % of current portfolio cost	50.6%
Total Dividends	£773.41		+£0
Total Profit from sales	£6,144.17		-£59.46
Average monthly cash profit	£512.04		-£13.51
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	14.9%

The cost went up £1,417, but that's a temporary situation. I need to sell something over the next few weeks to return that £1,417 back to my current account, as it was "borrowed" in order to max out my ISA for the year, with the aim of selling from my standard account to make it up.

The sell value is up £568, partly helped by me selling off shares that were at a loss as well as making profit, but £500 of that is from share price rises. No dividends yet again - it seems like ages since the last one, and profit from sales takes a regrettable £59 drop due to selling more things at a loss than I would have liked.

Year 2 projected monthly performance is still mental and will take a few months to settle to a realistic amount, and the average overall monthly profit took a bigger than usual dip because of the losses. The percentage return is less than 15% now, but as my target is 10% I'm still happy. When the portfolio cost comes down in the next few weeks it may go back above 15%.

Just look at that green line go! The deficit is only £1,600 now, but some frustration that the trend line isn't quite parallel yet.

Here's the SIPP after week 42

			Weekly Change
Portfolio cost	£14,932.06		+£158.55
Portfolio sell value (bid price - commission)	£16,454.21	(+10.2%)	+£445.50
Potential profits	£2,036.97		+£426.06
Dividends	£262.15		+£0
Profit from sales	£2,349.86		+£0
Average monthly cash profit	£265.61		-£6.48
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	21.3%

The monthly savings plan was invested in JLG:John Laing Group which accounts for the increase in cost. The value did well, climbing £445, nearly all of which was down to increasing profit. ALM:Allied Mind and OPTI:Optibiotix are responsible for the biggest losses, with TRX:Tissue Regenix and WRES:W Resources each having a small loss. Everything else is happily in profit.

No dividends or sales, so the monthly performance dips a small amount but projected profit is still over 20%.

A nice widening gap is just what I want to see.

The ill-fated trading account looks like this after week 8

			Weekly Change
Portfolio cost	£499.95		+£0
Cash	£0.05		+£0
Portfolio sell value (bid price - commission)	£444.67	(-11.1%)	+£0
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	£0		+£0
Average monthly cash profit	£0		+£0
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	0%

Absolutely no change whatsoever, after promising gains early in the week for SLP:Sylvania Platinum were cancelled out at the end of the week.

Although the green line is flat, the trend line is still going in the right direction.

That's it for another week. Not sure if there's any news planned for next week. KIBO:Kibo Mining may announce the cutoff date for the gold mine shares. Some say they may suspend trading while it's sorted out. There's a risk there may be a big sell-off when they resume, but it should be short lived. I keep hoping for news from OPTI:Optibiotix, as a reversal in fortunes for the share price would sort out a massive chunk of my paper loss. The big target next week is to get the overall combined portfolios in the black. Last week they were £200 away. At the end of this week they are just £129 away. Steady progress and no nasty surprises would be much appreciated. That means you Fed - no messing with interest rates thank you very much!